NCT01183247View on ClinicalTrials.gov

An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Comparative StudyImmunosuppressive Agents
Interventions
DRUG

Rapamycin

Add rapamycin de novo to tacrolimus and MMF

DRUG

Everolimus

Add everolimus de novo to tacrolimus and MMF

DRUG

Prednisone

Add prednisone de novo to tacrolimus and MMF

Trial Locations (1)

4031

Clinic for transplantation immunology and nephrology, Basel

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER